Athelas

Athelas is a healthcare technology company that develops medical devices and software solutions to improve patient care and outcomes. Their primary product, the Athelas Home, is an FDA-cleared in-home blood diagnostic device that allows patients to remotely monitor their immune system and key hematological parameters from a single drop of blood.

Key features:
- Remote Blood Monitoring: Measures white blood cells, neutrophils, platelets, hemoglobin, and other key biomarkers from home
- Early Detection: Enables early identification of conditions like infections, leukemia, and neutropenia
- AI-Powered Analysis: Utilizes advanced optical imaging and artificial intelligence for accurate results
- FDA Clearance: Approved for home use in 2022
- Comprehensive Software Suite: Includes Athelas Scribe for clinical documentation and Athelas RCM for revenue cycle management

How it works:
1. Patient collects a drop of blood using the Athelas Home device
2. Device uses optical imaging to analyze the blood sample
3. AI-powered software processes the data and generates results
4. Results are securely transmitted to healthcare providers for review
5. Clinicians can monitor patient health remotely and intervene if necessary

Use of AI:
- Blood Analysis: AI algorithms interpret optical imaging data to measure blood parameters
- Clinical Documentation: Athelas Scribe uses advanced language models to generate clinical notes and summaries
- Revenue Cycle Management: AI-driven insights optimize financial performance for healthcare practices

AI foundation model:
Information not provided

Target users:
- Chronically ill patients, especially those undergoing cancer treatment or taking immunosuppressive medications
- Oncologists and clinicians treating immunosuppressed patients
- Healthcare practices and systems seeking to improve clinical documentation and revenue cycle management

How to access:
- Athelas Home device: Available for purchase by healthcare providers and patients
- Athelas Scribe and RCM services: Offered on a subscription basis
- Pricing information is not publicly available

Company information:
- Founded: 2015
- Headquarters: Mountain View, California
- Funding: $151 million raised from investors including AIX Ventures, ASDF Ventures, Browder Capital, Greenoaks Capital Partners, and Seven Seven Six